A recent study suggests that individuals taking GLP-1 medications may have an 18% lower risk of developing age-related macular degeneration (AMD), a condition affecting central vision. This finding, based on health records of nearly 158,000 adults aged 60 and older, indicates a…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
Numerous lawsuits have been initiated in the United States against companies producing GLP-1 medications, such as Ozempic and Mounjaro, claiming these drugs may lead to a rare eye…
A recent study involving over 121,000 older adults suggests that nitrogen-containing bisphosphonates, commonly used to treat osteoporosis, may be associated with a 16% lower risk…
Lettuce, often overlooked as mere decoration on plates, is a nutrient-rich vegetable that offers significant health benefits. With high levels of vitamins K and A, antioxidants, a…
In a pioneering medical case, scientists injected mitochondria extracted from a woman's leg into her eyes to address severe vision loss. Although the procedure did not restore her…
A recent study reveals that Greenland sharks, the longest-living vertebrates, may live up to 400 years without experiencing significant retinal degeneration. Researchers found tha…
A significant trial involving 2,832 older adults found that memory training did not improve memory performance compared to untrained controls ten years later. While reasoning and…
Dr. Yogesh Kumar Chhabra from Fortis Hospital reveals that nearly 8 out of 10 people in India are living with high blood pressure, diabetes, or prediabetes, highlighting a growing…
Recent research highlights the potential benefits of GLP-1 receptor agonists, commonly used for diabetes and obesity management, suggesting they may also lower the risk of age-rel…
A recent study published in Diabetes, Obesity and Metabolism indicates that GLP-1 drugs, commonly used to treat type 2 diabetes and obesity, may also lower the risk of age-related…